Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.concorddrugs.in | |
Market Cap | 36.51 Cr. | |
Enterprise Value(EV) | 53.40 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.98 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 37.45 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 40.73 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 35.16 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.04 | Calculated using Price: 36.51 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,000 Shares |
FaceValue | 10 | |
About Concord Drugs Ltd. | ||
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. |
1 Day |
|
-0.11% |
1 Week |
|
-5.83% |
1 Month |
|
-4.12% |
3 Month |
|
-15.76% |
6 Month |
|
+2.04% |
1 Year |
|
+23.10% |
2 Year |
|
+18.93% |
5 Year |
|
+59.78% |
10 Year |
|
2 years | 2022-03 | 2023-03 | |
Return on Equity (%) | 5.62 | 3.31 | |
Return on Capital Employed (%) | 8.77 | 6.32 | |
Return on Assets (%) | 2.82 | 1.72 |
Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 28 | 32 | 33 | |
Non Curr. Liab. | 4 | 5 | 5 | |
Curr. Liab. | 24 | 22 | 21 | |
Minority Int. | ||||
Equity & Liab. | 56 | 58 | 59 | |
Non Curr. Assets | 15 | 15 | 14 | |
Curr. Assets | 42 | 43 | 45 | |
Misc. Exp. not W/O | ||||
Total Assets | 56 | 58 | 59 |
Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 59 | 52 | 42 | |
Other Income | 0 | 0 | ||
Total Income | 59 | 52 | 42 | |
Total Expenditure | -53 | -48 | -37 | |
PBIDT | 6 | 5 | 5 | |
Interest | -2 | -2 | -2 | |
Depreciation | -2 | -2 | -1 | |
Taxation | -1 | 0 | 0 | |
Exceptional Items | ||||
PAT | 2 | 1 | 1 | |
Minority Interest | ||||
Share Associate | ||||
Other Related Items | ||||
Consolidated Net Profit | 2 | 1 | 1 | |
Adjusted EPS | 2 | 1 | 1 |
Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 2 | |
Cash Fr. Inv. | -2 | -2 | |
Cash Fr. Finan. | 2 | 1 | |
Net Change | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 |
Mon, 15 Apr 2024
Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 . Certificate Under regulation 74(5) of SEBI ( Depositories and Participants) Regulation 2018. |
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate Under Regulation 74(5) of SEBI (DP) Regulation 2018. |
Fri, 29 Mar 2024
Closure of Trading Window Intimation of trading window closure |
Fri, 19 Apr 2024 |
High Delivery Percentage |
Opening at Low |
Making Lower Lows for 2 Days |
High Decrease in 3 Months |
MFI Trending Down |